0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Anomalous Absorptivity of Lens Proteins due to a Fluorogen

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The high molar absorptivity (at 280 nm of γ-crystallin and the insoluble protein fraction derived from the ocular lens of the dogfish is due to the presence of a fluorescent compound. The fluorogen was isolated and purified and partially characterized by UV and fluorescence spectra. The structural proteins of the ocular lens in almost all species (except for the Avian species) consist of 3 soluble fractions known as α-, β- and γ-crystallins and an insoluble portion frequently referred to as the albuminoid fraction. In the γ-fraction derived from 4 species studied in this laboratory (rat, dogfish, bovine and human) anomalously high E<sup>1%</sup><sub>1cm</sub> values (at 280 nm) have been reported [1–3]. A similar situation has also been noted in the insoluble protein fraction derived from 2 species, namely the rat and dogfish lens. The purpose of this paper is to determine the basis for the high absorptivity in the 280 nm region observed with γ-crystallin and the insoluble protein fraction derived from the ocular lens of the dogfish (Mustella canis).

          Related collections

          Author and article information

          Journal
          ORE
          Ophthalmic Res
          10.1159/issn.0030-3747
          Ophthalmic Research
          S. Karger AG
          0030-3747
          1423-0259
          1970
          1970
          27 November 2009
          : 1
          : 6
          : 338-343
          Affiliations
          Department of Ophthalmology (Experimental), McGill University, Montreal, Quebec
          Article
          264533 Ophthal Res 1970;1:338–343
          10.1159/000264533
          © 1970 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 6
          Categories
          Paper

          Comments

          Comment on this article